University of Houston1mon
Pharmaceutical Health Outcomes and Policy
Traditional and innovative areas of pharmaceutical health outcomes research include pharmacoepidemiology, pharmacoeconomics, comparative effectiveness research, patient-centered outcomes research and ...
Commonwealth Fund6y
Aaron S. Kesselheim
Aaron S. Kesselheim, M.D., J.D., M.P.H., is a professor of Medicine at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of ...
The New England Journal of Medicine9mon
Interview with Dr. Jerry Avorn on the 21st Century Cures Act’s potential implications for drug development and safety.
Jerry Avorn is a professor of medicine at Harvard Medical School and chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. Stephen Morrissey ...
Kaleido Scope3y
Building and InnovatinG Digital HeAlth Technology and Analytics (BIGDATA)
He is Co-Director of the UAB PharmacoEpidemiology and pharmacoEconomics Research (PEER) unit, and UAB PI of the PCORI funded ARthritis Patient Partnership with Comparative Effectiveness Researchers ...
Medscape27d
How Does End of Life Impact Diabetes Care?
The study was led by Alexander Kutz, MD, MPH, MSc, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School ...